| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 2-Yr Return |
|---|---|---|---|---|---|
|
BBIO
BridgeBio Pharma
|
Jun 17, 2026 | BUY |
Strong Buy
+38.7% avg upside
34 analysts
|
$98.00
47.97% Upside
|
+0.0% |
|
PTCT
PTC Therapeutics
|
May 08, 2026 | BUY |
Buy
-1.5% avg upside
29 analysts
|
$95.00
20.19% Upside
|
+6.6% |
|
INSM
Insmed
|
May 08, 2026 | BUY |
Strong Buy
+82.2% avg upside
36 analysts
|
$185.00
93.07% Upside
|
-2.9% |
|
JAZZ
Jazz Pharmaceuticals
|
May 06, 2026 | BUY |
Strong Buy
-1.8% avg upside
35 analysts
|
$239.00
6.31% Upside
|
-1.7% |
|
ALNY
Alnylam Pharma
|
May 01, 2026 | HOLD |
Strong Buy
+23.6% avg upside
51 analysts
|
$377.00
35.59% Upside
|
-4.5% |
|
IONS
Ionis Pharmaceuticals
|
Apr 10, 2026 | BUY |
Strong Buy
+13.3% avg upside
43 analysts
|
$104.00
40.33% Upside
|
-2.5% |
|
MIST
Milestone Pharmaceuticals
|
Apr 09, 2026 | BUY |
Strong Buy
+537.4% avg upside
7 analysts
|
$6.00
361.46% Upside
|
-35.3% |
|
RAPP
Rapport Therapeutics, Inc.
|
Apr 09, 2026 | BUY |
Strong Buy
+45.9% avg upside
12 analysts
|
$66.00
76.76% Upside
|
+7.7% |
|
UTHR
United Therapeutics
|
Apr 09, 2026 | BUY |
Strong Buy
-18.7% avg upside
26 analysts
|
$700.00
30.53% Upside
|
-6.6% |
|
PRAX
Praxis Precision Medicines
|
Apr 08, 2026 | BUY |
Strong Buy
+91.5% avg upside
24 analysts
|
$815.00
188.62% Upside
|
-15.7% |
|
KROS
Keros Therapeutics
|
Mar 05, 2026 | BUY |
Strong Buy
+139.0% avg upside
21 analysts
|
$20.00
87.85% Upside
|
-10.3% |
|
MNKD
MannKind
|
Feb 27, 2026 | BUY |
Buy
+78.6% avg upside
22 analysts
|
$7.00
77.67% Upside
|
+0.9% |
|
WVE
Wave Life Sciences
|
Sep 04, 2025 | BUY |
Strong Buy
+260.5% avg upside
28 analysts
|
$18.00
192.16% Upside
|
-24.7% |
|
LQDA
Liquidia Technologies
|
Aug 13, 2025 | BUY |
Strong Buy
-28.5% avg upside
15 analysts
|
$31.00
56.36% Downside
|
+172.4% |
|
TECX
Tectonic Therapeutic
|
Aug 07, 2025 | BUY |
Strong Buy
+88.0% avg upside
24 analysts
|
$101.00
236.54% Upside
|
+27.2% |
|
RARE
Ultragenyx Pharmaceutical
|
Jul 09, 2025 | BUY |
Strong Buy
+142.1% avg upside
36 analysts
|
$65.00
136.88% Upside
|
-44.2% |
|
SVRA
Savara
|
May 28, 2025 | BUY |
Strong Buy
+57.8% avg upside
17 analysts
|
$7.00
27.23% Upside
|
+136.2% |
|
IRON
Disc Medicine
|
May 08, 2025 | BUY |
Strong Buy
+20.2% avg upside
21 analysts
|
$91.00
28.61% Upside
|
+58.2% |
|
PLRX
Pliant Therapeutics
|
Mar 04, 2025 | HOLD |
Buy
+1821.1% avg upside
21 analysts
|
$3.00
158.71% Upside
|
-8.9% |
|
BV
BrightView Holdings
|
Aug 22, 2024 | HOLD |
Strong Buy
+24.5% avg upside
27 analysts
|
$16.00
22.54% Upside
|
-17.9% |
|
JBIO
Jade Biosciences
|
Jun 17, 2024 | HOLD |
Strong Buy
+232.9% avg upside
16 analysts
|
$70.00
316.14% Upside
|
-70.0% |
|
ASND
Ascendis Pharma
|
Jun 13, 2023 | HOLD |
Strong Buy
+17.0% avg upside
24 analysts
|
$89.00
61.40% Downside
|
+83.8% |
|
VRDN
Viridian Therapeutics
|
Jun 13, 2023 | BUY |
Strong Buy
+103.7% avg upside
32 analysts
|
$51.00
206.69% Upside
|
-40.2% |
|
BMRN
BioMarin Pharmaceutical
|
Jun 13, 2023 | BUY |
Strong Buy
+72.8% avg upside
52 analysts
|
$120.00
119.32% Upside
|
-40.7% |
|
SPRB
Spruce Biosciences
|
May 16, 2023 | BUY |
Strong Buy
+90.8% avg upside
14 analysts
|
$4.00
92.38% Downside
|
-97.0% |
|
KURA
Kura Oncology
|
May 11, 2023 | BUY |
Strong Buy
+161.3% avg upside
26 analysts
|
$26.00
161.77% Upside
|
-53.5% |
|
ABCL
AbCellera Biologics
|
May 05, 2023 | BUY |
Strong Buy
+137.9% avg upside
15 analysts
|
$28.00
406.43% Upside
|
-63.4% |
|
IFRX
InflaRx
|
Apr 05, 2023 | SELL |
Buy
+390.4% avg upside
11 analysts
|
$2.00
10.53% Upside
|
+83.4% |
|
BCAB
BioAtla
|
Mar 24, 2023 | HOLD |
Strong Buy
+2518.3% avg upside
13 analysts
|
$8.00
118.87% Upside
|
-84.3% |
|
DMRA
Damora Therapeutics
|
Mar 10, 2023 | BUY |
Strong Buy
+28.3% avg upside
19 analysts
|
$6.00
71.76% Downside
|
· |
|
ALXO
ALX Oncology Holdings
|
Mar 10, 2023 | BUY |
Strong Buy
+1072.8% avg upside
11 analysts
|
$34.00
2122.18% Upside
|
-83.4% |
|
OABI
OmniAb
|
Dec 16, 2022 | BUY |
Strong Buy
+232.4% avg upside
10 analysts
|
$13.00
455.62% Upside
|
+8.6% |
|
EDIT
Editas Medicine
|
Nov 17, 2022 | HOLD |
Buy
+407.9% avg upside
33 analysts
|
$13.00
383.23% Upside
|
-75.8% |
|
PYXS
Pyxis Oncology
|
Aug 15, 2022 | BUY |
Strong Buy
+240.3% avg upside
13 analysts
|
$14.00
589.60% Upside
|
+22.9% |
|
ABSI
AbSci
|
Aug 12, 2022 | BUY |
Strong Buy
+36.3% avg upside
18 analysts
|
$14.00
89.03% Upside
|
-23.4% |
|
ARGX
Argenx Se
|
Mar 03, 2022 | HOLD |
Strong Buy
-15.8% avg upside
46 analysts
|
$319.00
63.58% Downside
|
+44.5% |
|
IMVT
Immunovant
|
Aug 02, 2021 | SELL |
Strong Buy
+8.9% avg upside
24 analysts
|
$7.00
80.19% Downside
|
-190.7% |
|
AMGN
Amgen
|
Apr 28, 2021 | BUY |
Buy
-11.6% avg upside
57 analysts
|
$259.00
23.24% Downside
|
+7.9% |
|
GB:0QW0
arGEN X
|
Oct 22, 2020 | HOLD |
Strong Buy
-22.9% avg upside
24 analysts
|
$240.00
68.89% Downside
|
· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.